Published on November 11, 2023, 12:58 am
A tragic incident in Australia has raised concerns about the use of weight loss drugs and their potential consequences. Trish Webster, a 56-year-old woman, started taking a prescribed drug called Ozempic in an attempt to lose weight before her daughter’s wedding. Ozempic is a GLP-1 drug commonly used to treat type 2 diabetes but has also received FDA approval for chronic weight management.
The popularity of Ozempic has grown recently due to social media influencers and celebrities sharing their experiences with the drug as a means of keeping their weight down. This has led many people to seek out this drug for weight loss purposes. Ozempic works by mimicking the natural hormone GLP-1, which sends signals to the brain that you feel full or satisfied, even if you are not.
Trish’s husband, Roy Webster, revealed that his wife had seen the drug being advertised on TV and decided to obtain a prescription from her doctor. Despite experiencing sickness and diarrhea symptoms, Trish continued taking the drug in her determination to shed a few pounds before the big day. She even switched to another weight loss drug called Saxenda after three months of using Ozempic.
Tragically, Trish’s weight loss came at a terrible cost. Her husband claimed that she experienced severe side effects such as constant vomiting, diarrhea, and nausea. On January 16th, things took a turn for the worse when Trish collapsed at home and died later that night from what was noted on her death certificate as an ‘acute gastrointestinal illness.’
Roy Webster believes that these drugs played a role in the tragedy that unfolded. He expressed his regret over not knowing about the potential risks associated with them and stated that he would have discouraged his wife from taking them if he had been aware.
Weight loss drugs like Ozempic have been associated with various side effects and symptoms. According to reports submitted to the FDA, there have been approximately 8,500 cases of gastrointestinal issues related to the use of these drugs. Trish Webster’s symptoms align with this pattern.
In response to the incident, Novo Nordisk, the pharmaceutical company that manufactures Ozempic, issued a statement emphasizing that they do not support the use of Ozempic specifically for weight loss. They claim that patient safety is their utmost priority and acknowledge that gastrointestinal events are known side effects of GLP-1 drugs.
It is essential for individuals considering weight loss medications to consult with healthcare professionals and make informed decisions based on their individual medical profiles. It is also crucial for pharmaceutical companies to continually monitor the safety profile of their products and collaborate closely with authorities to ensure patient safety.
The tragic story of Trish Webster serves as a reminder of the potential risks associated with weight loss drugs. While these medications may offer benefits for some individuals, it is crucial to weigh the potential side effects and discuss them thoroughly with healthcare professionals before deciding to use them. Safety should always be a top priority when embarking on any weight loss journey.